Seventy-two years after the first antipsychotic, Thorazine, was approved, psychiatry is now seriously discussing the need to ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Older patients ...

Vanda Pharmaceuticals is riding a regulatory roller coaster over the last few months. | Vanda Pharmaceuticals is riding a regulatory roller coaster over the last few months with two FDA approvals and ...

The FDA OKs pill schizophrenia and bipolar disorder treatment with Bysanti, a new atypical antipsychotic approved for adults.

This study investigated the 1-year incidence of extrapyramidal symptoms (EPS), as well as the incremental economic burden, in patients with schizophrenia initiating atypical antipsychotics. Objectives ...

Pharmaceutical companies have recently paid out the largest legal settlements in U.S. history — including the largest criminal fines ever imposed on corporations — for illegally marketing ...

Epstein R.A., Bobo W.V., Shelton R.C., Arbogast P.G., Morrow J.A., Cooper W.O. Increasing use of atypical antipsychotics and anticonvulsants during pregnancy ...

Please provide your email address to receive an email when new articles are posted on . “We conducted this study because psychiatric disorders are common among women of reproductive age and while ...

By Sneha S K and Kunal Das Feb 20 (Reuters) - The U.S. Food and Drug Administration has approved Vanda Pharmaceuticals' drug ...

As mentioned in section 4, conventional and atypical antipsychotics show significant differences both in receptor binding profile and in pharmacokinetic characteristics; we have focused in particular ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window ...